(CRM) Salesforce.com - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US79466L3024
CRM Platform, Agentforce, Data Cloud, Slack, Tableau
Dividends
| Dividend Yield | 0.71% |
| Yield on Cost 5y | 0.75% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 15.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 32.0% |
| Value at Risk 5%th | 49.1% |
| Relative Tail Risk | -6.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.97 |
| Alpha | -43.89 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.477 |
| Beta | 1.022 |
| Beta Downside | 1.069 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.37% |
| Mean DD | 13.35% |
| Median DD | 10.33% |
Description: CRM Salesforce.com December 01, 2025
Salesforce (CRM) is a global provider of customer relationship management (CRM) software that links companies with their customers across sales, service, marketing, commerce, and analytics. Its product suite now includes Agentforce (an AI-driven agent layer), Data Cloud (a unified data engine), industry-specific AI agents, Salesforce Starter for SMBs, Slack for workplace collaboration, Tableau for end-to-end analytics, and a suite of field-service and commerce solutions. Strategic partnerships, notably with Google Workspace, embed Agentforce 360 and the emerging Salesforce Gemini AI across sales and IT workflows.
Key recent metrics: FY2024 revenue reached $27.1 billion, up ~15% YoY, with subscription and support revenue comprising roughly 90% of total-a sign of high-margin, recurring cash flow. The broader CRM software market is expanding at a ~12% CAGR, driven by accelerating digital transformation and enterprise AI adoption, which underpins Salesforce’s growth outlook. Additionally, the company’s AI-centric initiatives (Gemini, Agentforce) have begun to lift average contract values by an estimated 8% YoY, reflecting premium pricing for AI-enhanced capabilities.
For a deeper, data-driven valuation perspective, you might explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (6.66b TTM) > 0 and > 6% of Revenue (6% = 2.37b TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 0.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.09% (prev 2.36%; Δ 4.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 13.17b > Net Income 6.66b (YES >=105%, WARN >=100%) |
| Net Debt (-7.56b) to EBITDA (11.73b) ratio: -0.64 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (962.0m) change vs 12m ago -1.13% (target <= -2.0% for YES) |
| Gross Margin 77.65% (prev 76.35%; Δ 1.30pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.64% (prev 39.56%; Δ 2.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 62.07 (EBITDA TTM 11.73b / Interest Expense TTM 135.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.97
| (A) 0.03 = (Total Current Assets 25.33b - Total Current Liabilities 22.53b) / Total Assets 97.57b |
| (B) 0.19 = Retained Earnings (Balance) 18.99b / Total Assets 97.57b |
| (C) 0.09 = EBIT TTM 8.38b / Avg Total Assets 94.88b |
| (D) 0.53 = Book Value of Equity 19.04b / Total Liabilities 36.24b |
| Total Rating: 1.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.34
| 1. Piotroski 6.0pt |
| 2. FCF Yield 6.08% |
| 3. FCF Margin 31.64% |
| 4. Debt/Equity 0.05 |
| 5. Debt/Ebitda -0.64 |
| 6. ROIC - WACC (= -0.14)% |
| 7. RoE 11.03% |
| 8. Rev. Trend 98.54% |
| 9. EPS Trend 93.27% |
What is the price of CRM shares?
As of December 03, 2025, the stock is trading at USD 234.71 with a total of 7,624,076 shares traded.
Over the past week, the price has changed by +0.25%, over one month by -10.19%, over three months by -7.02% and over the past year by -28.66%.
Over the past week, the price has changed by +0.25%, over one month by -10.19%, over three months by -7.02% and over the past year by -28.66%.
Is CRM a buy, sell or hold?
Salesforce.com has received a consensus analysts rating of 4.22.
Therefore, it is recommended to buy CRM.
- Strong Buy: 28
- Buy: 13
- Hold: 12
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the CRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 328.4 | 39.9% |
| Analysts Target Price | 328.4 | 39.9% |
| ValueRay Target Price | 239.9 | 2.2% |
CRM Fundamental Data Overview November 29, 2025
Market Cap USD = 218.11b (218.11b USD * 1.0 USD.USD)
P/E Trailing = 33.1132
P/E Forward = 17.9856
P/S = 5.5215
P/B = 3.5416
P/EG = 1.0807
Beta = 1.243
Revenue TTM = 39.50b USD
EBIT TTM = 8.38b USD
EBITDA TTM = 11.73b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 580.0m USD (from shortTermDebt, last quarter)
Debt = 2.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.56b USD (from netDebt column, last quarter)
Enterprise Value = 205.54b USD (218.11b + Debt 2.80b - CCE 15.37b)
Interest Coverage Ratio = 62.07 (Ebit TTM 8.38b / Interest Expense TTM 135.0m)
FCF Yield = 6.08% (FCF TTM 12.50b / Enterprise Value 205.54b)
FCF Margin = 31.64% (FCF TTM 12.50b / Revenue TTM 39.50b)
Net Margin = 16.87% (Net Income TTM 6.66b / Revenue TTM 39.50b)
Gross Margin = 77.65% ((Revenue TTM 39.50b - Cost of Revenue TTM 8.83b) / Revenue TTM)
Gross Margin QoQ = 78.10% (prev 76.96%)
Tobins Q-Ratio = 2.11 (Enterprise Value 205.54b / Total Assets 97.57b)
Interest Expense / Debt = 2.39% (Interest Expense 67.0m / Debt 2.80b)
Taxrate = 21.57% (519.0m / 2.41b)
NOPAT = 6.57b (EBIT 8.38b * (1 - 21.57%))
Current Ratio = 1.12 (Total Current Assets 25.33b / Total Current Liabilities 22.53b)
Debt / Equity = 0.05 (Debt 2.80b / totalStockholderEquity, last quarter 61.33b)
Debt / EBITDA = -0.64 (Net Debt -7.56b / EBITDA 11.73b)
Debt / FCF = -0.61 (Net Debt -7.56b / FCF TTM 12.50b)
Total Stockholder Equity = 60.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.83% (Net Income 6.66b / Total Assets 97.57b)
RoE = 11.03% (Net Income TTM 6.66b / Total Stockholder Equity 60.42b)
RoCE = 12.17% (EBIT 8.38b / Capital Employed (Equity 60.42b + L.T.Debt 8.44b))
RoIC = 9.54% (NOPAT 6.57b / Invested Capital 68.86b)
WACC = 9.68% (E(218.11b)/V(220.91b) * Re(9.78%) + D(2.80b)/V(220.91b) * Rd(2.39%) * (1-Tc(0.22)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 76.01% ; FCFE base≈12.08b ; Y1≈14.91b ; Y5≈25.43b
Fair Price DCF = 334.9 (DCF Value 318.79b / Shares Outstanding 952.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 93.27 | EPS CAGR: 24.75% | SUE: 1.37 | # QB: 1
Revenue Correlation: 98.54 | Revenue CAGR: 11.25% | SUE: 1.72 | # QB: 2
EPS next Year (2027-01-31): EPS=12.71 | Chg30d=+0.007 | Revisions Net=+1 | Growth EPS=+11.7% | Growth Revenue=+9.0%
P/E Trailing = 33.1132
P/E Forward = 17.9856
P/S = 5.5215
P/B = 3.5416
P/EG = 1.0807
Beta = 1.243
Revenue TTM = 39.50b USD
EBIT TTM = 8.38b USD
EBITDA TTM = 11.73b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 580.0m USD (from shortTermDebt, last quarter)
Debt = 2.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.56b USD (from netDebt column, last quarter)
Enterprise Value = 205.54b USD (218.11b + Debt 2.80b - CCE 15.37b)
Interest Coverage Ratio = 62.07 (Ebit TTM 8.38b / Interest Expense TTM 135.0m)
FCF Yield = 6.08% (FCF TTM 12.50b / Enterprise Value 205.54b)
FCF Margin = 31.64% (FCF TTM 12.50b / Revenue TTM 39.50b)
Net Margin = 16.87% (Net Income TTM 6.66b / Revenue TTM 39.50b)
Gross Margin = 77.65% ((Revenue TTM 39.50b - Cost of Revenue TTM 8.83b) / Revenue TTM)
Gross Margin QoQ = 78.10% (prev 76.96%)
Tobins Q-Ratio = 2.11 (Enterprise Value 205.54b / Total Assets 97.57b)
Interest Expense / Debt = 2.39% (Interest Expense 67.0m / Debt 2.80b)
Taxrate = 21.57% (519.0m / 2.41b)
NOPAT = 6.57b (EBIT 8.38b * (1 - 21.57%))
Current Ratio = 1.12 (Total Current Assets 25.33b / Total Current Liabilities 22.53b)
Debt / Equity = 0.05 (Debt 2.80b / totalStockholderEquity, last quarter 61.33b)
Debt / EBITDA = -0.64 (Net Debt -7.56b / EBITDA 11.73b)
Debt / FCF = -0.61 (Net Debt -7.56b / FCF TTM 12.50b)
Total Stockholder Equity = 60.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.83% (Net Income 6.66b / Total Assets 97.57b)
RoE = 11.03% (Net Income TTM 6.66b / Total Stockholder Equity 60.42b)
RoCE = 12.17% (EBIT 8.38b / Capital Employed (Equity 60.42b + L.T.Debt 8.44b))
RoIC = 9.54% (NOPAT 6.57b / Invested Capital 68.86b)
WACC = 9.68% (E(218.11b)/V(220.91b) * Re(9.78%) + D(2.80b)/V(220.91b) * Rd(2.39%) * (1-Tc(0.22)))
Discount Rate = 9.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 76.01% ; FCFE base≈12.08b ; Y1≈14.91b ; Y5≈25.43b
Fair Price DCF = 334.9 (DCF Value 318.79b / Shares Outstanding 952.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 93.27 | EPS CAGR: 24.75% | SUE: 1.37 | # QB: 1
Revenue Correlation: 98.54 | Revenue CAGR: 11.25% | SUE: 1.72 | # QB: 2
EPS next Year (2027-01-31): EPS=12.71 | Chg30d=+0.007 | Revisions Net=+1 | Growth EPS=+11.7% | Growth Revenue=+9.0%
Additional Sources for CRM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle